Skip to main content
. 2013 May;141(5):537–555. doi: 10.1085/jgp.201210887

Figure 8.

Figure 8.

Concentration–response curves from the model illustrating the concept of receptor reserve. Panels show predicted responses from the computational model for three different receptor densities (R was 500 µm−2 for A, “high density”; 25 µm−2 for B, “intermediate density;” and 1.25 for C, “low density”). The x axis represents agonist concentration in reduced units of concentration divided by Kd, the dissociation constant for receptors in the absence of G proteins. For reference, 1.0 on this axis corresponds to 2 µM Oxo-M or possibly 5 µM UTP. Curves show the responses of many signaling intermediates normalized to their extreme values (maxima or minima), with increasing species normalized to the maximum and decreasing species normalized so that 0 corresponds to the resting value and 1 corresponds to the minimum with receptor saturation. For A, PI 4-kinase and PIP2 5-kinase were accelerated during agonist as described in Fig. 7. For B, acceleration of PI 4-kinase and PIP 5-kinase was 20-fold less. For C, PI 4-kinase and PIP 5-kinase were not accelerated. The y-scaling was kept constant between A, B, and C with the following exceptions: B contains two traces “allRL” and two traces “Gα-PLC,” one of each on the same scale as in panel A to illustrate the difference in maximum amplitude and a second one of each that was rescaled to its maximum to better compare midpoints between A and B. In C, “allRL” and “Gα-PLC” are shown only rescaled to maximum. The dip in the PIP2 depletion curve between 0.005 and 0.02 agonist/Kd of A is probably an artifact of our model. It occurs because, for this concentration range, accelerated PIP2 synthesis outweighs PLC activation, leading to a net increase in PIP2. We have no direct evidence for this occurring in real cells, suggesting that the model (Fig. 7 E) introduces too much acceleration of PIP2 synthesis in this intermediate agonist concentration range.

HHS Vulnerability Disclosure